VIM and diabetes mellitus: In a single previously published case series (Roefs et al. 2017), vimentin/glucagon and vimentin/insulin co-staining were seen in deceased organ donors with and without type 2 diabetes, with higher numbers of co-expressing α-cells than β-cells and higher numbers of both altered phenotypes in diabetes.